Sigilon Therapeutics, Inc.

Sigilon Therapeutics, Inc.

Sigilon Therapeutics, Inc.

Overview
Date Founded

2015

Headquarters

100 Binney Street, Suite 600, Cambridge, MA, 02142, USA

Type of Company

Public

Employees (Worldwide)

11 - 50

Industries

Biotechnology

Company Description

Sigilon Therapeutics, Inc. engages in the research and development of therapeutic treatments for a wide range of chronic diseases. The company was founded by Daniel G. Anderson, Robert S. Langer Jr., Jose Oberholzer, Arturo Vegas, and Omid Veiseh on May 14, 2015 and is headquartered in Cambridge, MA.

Website

http://www.sigilon.com

Contact Data
Trying to get in touch with decision makers at Sigilon Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
GlobeNewswire
February 8, 2021
Sigilon Therapeutics Announces Preclinical Data in Multiple Lysosomal Diseases at the 17th Annual WORLDSymposium™
GlobeNewswire
January 13, 2021
Sigilon Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021
RelSci
January 8, 2021
Eli Lilly & Company purchased $5.4M worth of shares in Sigilon Therapeutics, Inc. in December 2020
Nasdaq
January 6, 2021
BUZZ-U.S. STOCKS ON THE MOVE-AmerisourceBergen, ReneSola Ltd, Big Tech stocks
GlobeNewswire
December 8, 2020
Sigilon Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
Robert Langer

Co-Founder

Omid Veiseh

Co-Founder

Arturo Vegas

Co-Founder

Daniel G. Anderson

Co-Founder

José Oberholzer

Co-Founder

Rogerio Vivaldi

President & Chief Executive Officer

Glenn Reicin

Chief Financial Officer

Devyn Smith

Chief Operating Officer

David Peritt

Chief Technology Officer

Matthew Kowalsky

Secretary & Chief Legal Officer

Board of Directors
Doug Cole

Managing Partner at Flagship Pioneering

Stephen Oesterle

Venture Partner of Cathay Health at Cathay Capital Private Equity SAS (China)

Eric Shaff

President & Chief Executive Officer at Seres Therapeutics, Inc.

John Cox

Chief Executive Officer at Repertoire Immune Medicines

Daniel G. Anderson

Co-Founder at Sigilon Therapeutics, Inc.

Kavita Patel

Former Venture Partner at New Enterprise Associates

Rogerio Vivaldi

President & Chief Executive Officer at Sigilon Therapeutics, Inc.

Robert Ruffolo, Jr.

Director at X-Vax Technology, Inc.

Jim Gilbert

Senior Partner at Flagship Pioneering

Trending People
Page Street Publishing Co.
Author Steve Wollett's new book "God's Assassin" is a spellbinding thriller foll... - PR Newswire
The Pratt & Whitney Co., Inc.
Damage to fan blade in United Boeing 777 engine consistent with metal fatigue -N... - Nasdaq
HSBC Holdings Plc
HSBC's annual profit falls 34% as COVID-19 takes toll - Nasdaq
Trending Organizations
Page Street Publishing Co.
Author Steve Wollett's new book "God's Assassin" is a spellbinding thriller foll... - PR Newswire
The Pratt & Whitney Co., Inc.
Damage to fan blade in United Boeing 777 engine consistent with metal fatigue -N... - Nasdaq
HSBC Holdings Plc
HSBC's annual profit falls 34% as COVID-19 takes toll - Nasdaq
Paths to Sigilon Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Sigilon Therapeutics, Inc.
Owners & Shareholders
Details Hidden
Flagship Pioneering

Flagship Pioneering seeks investment opportunities in companies located globally. The firm focuses on companies operating in the fields of therapeutics, life science tools & diagnostics, and bioenergy or cleantech. It provides financing for seed, early, and later-stage capital requirements. It acts as a lead investor. It also makes co-investments.

Details Hidden
Avidity Partners Management LP

Avidity Partners Management LP (APM) is a hedge fund manager headquartered in Dallas, Texas founded by Michael David Gregory. APM provides investment advice.

Details Hidden
HarbourVest Partners LLC

HarbourVest invests in companies across global primarily in US, China and Japan. The firm targets companies operating across a broad range of sectors. They provide financing for buyout, growth equity, mezzanine and direct co-investments.

Recent Transactions
Details Hidden

Sigilon Therapeutics, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Eli Lilly & Company

Transaction Advisors
Underwriter
Barclays Capital, Inc.

Advised onSigilon Therapeutics, Inc. issued USD Common Stock

Underwriter
Canaccord Genuity LLC

Advised onSigilon Therapeutics, Inc. issued USD Common Stock

Escrow Agent
Computershare Trust Co., NA

Advised onSigilon Therapeutics, Inc. issued USD Common Stock
Advisors & Consultants
Advisor
Paul K. Wotton

Chief Executive Officer, President & Director at Obsidian Therapeutics, Inc.

Advisor
Amy Bonanno

Clients
Eli Lilly & Company

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.
Key Stats and Financials As of 2019
Market Capitalization
$1.13B
Total Enterprise Value
Earnings Per Share
$-1.41
Revenue
$14.2M
Net Profit
$-43.9M
EBITDA
$-43.4M
EBITDAMargin
-306.95%
Total Debt
$115M
Total Equity
$-77.8M
Investors
Details Hidden
Flagship Pioneering

Flagship Pioneering seeks investment opportunities in companies located globally. The firm focuses on companies operating in the fields of therapeutics, life science tools & diagnostics, and bioenergy or cleantech. It provides financing for seed, early, and later-stage capital requirements. It acts as a lead investor. It also makes co-investments.

Details Hidden
The Vanguard Group, Inc.

The Vanguard Group is an American investment management company based in Malvern, Pennsylvania, that manages approximately $3.4 trillion[1] in assets. It is the largest provider of mutual funds and now the second-largest provider of exchange-traded funds (ETFs) in the world after BlackRock, with about $451 billion in ETF assets under management, as of March 2015.[3] It offers mutual funds and other financial products and services to retail and institutional investors in the United States and abroad. Founder and former chairman John C. Bogle is credited with the creation of the first index fund available to individual investors,[4] the popularization of index funds generally,[5] and driving costs down across the mutual fund industry.

Details Hidden
Doug Cole

Managing Partner at Flagship Pioneering

Suppliers
Massachusetts Institute of Technology Hospitals & Patient Services | Cambridge, MA

Massachusetts Institute of Technology (MIT) is a private research university located in Cambridge, Massachusetts, United States. MIT has five schools and one college, containing a total of 32 academic departments, with a strong emphasis on scientific, engineering, and technological education and research. Founded in 1861 in response to the increasing industrialization of the United States, the institute used a polytechnic university model and stressed laboratory instruction. MIT was elected to the Association of American Universities in 1934.

Competitors
Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

CRISPR Therapeutics AG Biotechnology - Zug, Che

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.

Roche Holding AG Pharmaceuticals - Basel, Switzerland

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Sigilon Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Sigilon Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Sigilon Therapeutics, Inc..